lactic acid has been researched along with Adenocarcinoma of Lung in 12 studies
Lactic Acid: A normal intermediate in the fermentation (oxidation, metabolism) of sugar. The concentrated form is used internally to prevent gastrointestinal fermentation. (From Stedman, 26th ed)
2-hydroxypropanoic acid : A 2-hydroxy monocarboxylic acid that is propanoic acid in which one of the alpha-hydrogens is replaced by a hydroxy group.
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the treatment of lung adenocarcinoma, targeting PFKFB3 would be a promising therapeutic strategy." | 1.48 | Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy. ( Ke, H; Li, X; Liu, J; Liu, Y; Qian, L; Tian, W; Yao, C; Zhang, J, 2018) |
| ") Thus, overall results suggest that nano-encapsulation of PD (NPD) increases drug bioavailability and thereby has a better chemo-preventive action against lung cancer in vivo and on A549 cells in vitro than that of PD." | 1.38 | Poly (lactide-co-glycolide) encapsulated extract of Phytolacca decandra demonstrates better intervention against induced lung adenocarcinoma in mice and on A549 cells. ( Bhadra, K; Das, J; Das, S; Khuda-Bukhsh, AR; Samadder, A, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 7 (58.33) | 2.80 |
| Authors | Studies |
|---|---|
| Zhao, F | 1 |
| Wang, Z | 1 |
| Li, Z | 2 |
| Liu, S | 1 |
| Li, S | 4 |
| Shang, S | 2 |
| Wang, MZ | 2 |
| Xing, Z | 2 |
| He, N | 2 |
| Guo, Z | 1 |
| Hu, L | 1 |
| Wang, Q | 1 |
| Wang, Y | 2 |
| Liu, XP | 1 |
| Chen, C | 1 |
| Hu, W | 1 |
| Chen, Z | 1 |
| Song, Y | 1 |
| Li, P | 1 |
| Gao, W | 1 |
| Zhao, M | 1 |
| Huang, C | 1 |
| Yang, L | 1 |
| Pan, B | 1 |
| Yang, S | 1 |
| Chang, J | 1 |
| Jin, Y | 1 |
| Zhao, G | 1 |
| Yue, D | 1 |
| Qie, S | 1 |
| Ren, L | 1 |
| Wang, M | 1 |
| He, T | 1 |
| Meng, D | 1 |
| Lv, W | 1 |
| Ye, J | 1 |
| Cheng, L | 1 |
| Hu, J | 1 |
| Flint, LE | 1 |
| Hamm, G | 1 |
| Ready, JD | 1 |
| Ling, S | 1 |
| Duckett, CJ | 1 |
| Cross, NA | 1 |
| Cole, LM | 1 |
| Smith, DP | 1 |
| Goodwin, RJA | 1 |
| Clench, MR | 1 |
| Li, X | 1 |
| Liu, J | 1 |
| Qian, L | 1 |
| Ke, H | 1 |
| Yao, C | 1 |
| Tian, W | 1 |
| Liu, Y | 1 |
| Zhang, J | 1 |
| Jiang, W | 1 |
| Wang, H | 1 |
| Cui, Y | 1 |
| Lei, Y | 1 |
| Xu, D | 1 |
| Jiang, N | 1 |
| Chen, Y | 1 |
| Sun, Y | 1 |
| Zhang, Y | 1 |
| Cao, J | 1 |
| Ke, Z | 1 |
| Liu, N | 1 |
| Luo, J | 1 |
| Kuang, D | 1 |
| Xu, S | 1 |
| Duan, Y | 1 |
| Xia, Y | 1 |
| Wei, Z | 1 |
| Xie, X | 1 |
| Yin, B | 1 |
| Chen, F | 1 |
| Luo, S | 1 |
| Liu, H | 1 |
| Wang, J | 1 |
| Jiang, K | 1 |
| Gong, F | 1 |
| Tang, ZH | 1 |
| Cheng, X | 1 |
| Li, H | 1 |
| Laurence, A | 1 |
| Wang, G | 1 |
| Yang, XP | 1 |
| Makinoshima, H | 1 |
| Takita, M | 1 |
| Saruwatari, K | 1 |
| Umemura, S | 1 |
| Obata, Y | 1 |
| Ishii, G | 1 |
| Matsumoto, S | 1 |
| Sugiyama, E | 1 |
| Ochiai, A | 1 |
| Abe, R | 1 |
| Goto, K | 1 |
| Esumi, H | 1 |
| Tsuchihara, K | 1 |
| Das, J | 1 |
| Das, S | 1 |
| Samadder, A | 1 |
| Bhadra, K | 1 |
| Khuda-Bukhsh, AR | 1 |
12 other studies available for lactic acid and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Identifying a lactic acid metabolism-related gene signature contributes to predicting prognosis, immunotherapy efficacy, and tumor microenvironment of lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Erlotinib Hydrochloride; Etoposide; Gefitinib; Humans; Immunologic Factors; | 2022 |
Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Humans; Lactic Acid; Lung Neoplasms; Programmed Cell Death 1 Receptor; Tumor | 2022 |
Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Humans; Lactic Acid; Lung Neoplasms; Programmed Cell Death 1 Receptor; Tumor | 2022 |
Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Humans; Lactic Acid; Lung Neoplasms; Programmed Cell Death 1 Receptor; Tumor | 2022 |
Lactate regulators contribute to tumor microenvironment and predict prognosis in lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Humans; Lactic Acid; Lung Neoplasms; Programmed Cell Death 1 Receptor; Tumor | 2022 |
Molecular Characterization and Prognosis of Lactate-Related Genes in Lung Adenocarcinoma.
Topics: Adenocarcinoma of Lung; DNA Copy Number Variations; Humans; Lactic Acid; Lung Neoplasms; Prognosis; | 2023 |
GRIN2D knockdown suppresses the progression of lung adenocarcinoma by regulating the E2F signalling pathway.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Cell Proliferation; Gene Expression Regulation, Neoplastic; | 2023 |
SYVN1-mediated ubiquitylation directs localization of MCT4 in the plasma membrane to promote the progression of lung adenocarcinoma.
Topics: Adenocarcinoma of Lung; Animals; Cell Membrane; Humans; Lactic Acid; Mice; Monocarboxylic Acid Trans | 2023 |
BZW2 Modulates Lung Adenocarcinoma Progression through Glycolysis-Mediated IDH3G Lactylation Modification.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Cell Line, Tumor; Cell Proliferation; Gene Expressi | 2023 |
Characterization of an Aggregated Three-Dimensional Cell Culture Model by Multimodal Mass Spectrometry Imaging.
Topics: Adenocarcinoma of Lung; Citric Acid; Glutamine; Humans; Lactic Acid; Lung Neoplasms; Multimodal Imag | 2020 |
Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Apoptosis; Bioma | 2018 |
Polymer nanofiber-based microchips for EGFR mutation analysis of circulating tumor cells in lung adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Base Sequence; Carcinoma, Non-Small-Cell Lung; Cell Count; C | 2018 |
Lactate inhibits ATP6V0d2 expression in tumor-associated macrophages to promote HIF-2α-mediated tumor progression.
Topics: Adenocarcinoma of Lung; Animals; Basic Helix-Loop-Helix Transcription Factors; Female; Gene Expressi | 2019 |
Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aerobiosis; Cell Line, Tumor; Cell Proliferation; ErbB Recep | 2015 |
Poly (lactide-co-glycolide) encapsulated extract of Phytolacca decandra demonstrates better intervention against induced lung adenocarcinoma in mice and on A549 cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Arsenites; bcl-2-Associated | 2012 |